GeneNews Ltd (TSE:GEN) shares fell 6.7% during mid-day trading on Tuesday . The company traded as low as C$0.14 and last traded at C$0.14. 559,775 shares changed hands during mid-day trading, a decline of 73% from the average session volume of 2,076,899 shares. The stock had previously closed at C$0.15.
The firm has a market cap of $23.80 million and a PE ratio of -4.41.
ILLEGAL ACTIVITY WARNING: “GeneNews (GEN) Stock Price Down 6.7%” was originally published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US and international copyright and trademark laws. The correct version of this piece of content can be read at https://www.chaffeybreeze.com/2019/04/11/genenews-gen-stock-price-down-6-7.html.
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Further Reading: What is a good rate of return for a mutual fund?
Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.